Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Arrowhead Pharmaceuticals Inc ARWR

Healthcare Biotechnology
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3,... see more

Current News (NDAQ:ARWR)

Arrowhead Pharmaceuticals to Participate in Upcoming March 2026 Events

Business Wire 10 days ago

Arrowhead Pharmaceuticals Reports Fiscal 2026 First Quarter Results

Business Wire February 5, 2026

Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-DIMER-PA - the First Dual Functional RNAi Therapeutic for the Treatment of Mixed Hyperlipidemia

Business Wire January 27, 2026

Arrowhead Pharmaceuticals to Webcast Fiscal 2026 First Quarter Results

Business Wire January 20, 2026

Arrowhead Pharmaceuticals Prices Upsized Offerings of Convertible Senior Notes, Common Stock and Pre-Funded Warrants

Business Wire January 7, 2026

Arrowhead Pharmaceuticals Announces NMPA Approval of REDEMPLO® (plozasiran) for Familial Chylomicronemia Syndrome (FCS) in China

Business Wire January 7, 2026

Arrowhead Pharmaceuticals Announces Proposed Offerings of Convertible Senior Notes and Common Stock

Business Wire January 6, 2026

Arrowhead Pharmaceuticals Announces Interim Clinical Data on RNAi-based Obesity Candidates Showing Weight Loss in Obese Patients with Diabetes and Improved Measures of Body Composition

Business Wire January 6, 2026

Arrowhead Pharmaceuticals Announces Health Canada Approval of REDEMPLO(TM) (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS)

Business Wire January 5, 2026
View More News ››

Opinion & Analysis (NDAQ:ARWR)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:ARWR)

Buy buddy buy because it's taking off this morning.

Otherwise FOMO
coolfooldumbguy - January 6, 2026

SHORT STILL

I heard about ARWR the other day onBULLALERTS Its looking like an interesting play.
lebaoxuiyo15 - November 2, 2022

This stock

Is this stock good at this price? I see they have many medicines in the pipeline. I find they have everything to bring a product on the...
maartenverhoeve - April 10, 2020

Stock is on Fire - Remarkable Management Team

The management team of this company is stellar. What an incredible journey this company has had over the past year.
eqwitty - October 31, 2019

RE:New To The Board With News For The Board

That previous article is apparently very old...sorry :0(
oldsilversurfer - September 28, 2014

New To The Board With News For The Board

http://www.azonano.com/article.aspx?ArticleID=797
oldsilversurfer - September 28, 2014
View more Bullboard ››

Southern Silver Exploration Corp.

Southern Silver Exploration Corp.

Southern Silver Exploration Corp., an exploration stage company, acquires, explores, and develops natural resource properties ...
View More »

Podcasts